Related Experiment Videos
Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase
1Department of Surgery, Children's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Abstract:
Receptor tyrosine kinases regulate cell behavior by activating specific signal transduction cascades. Epidermal growth factor (EGF) receptor tyrosine kinases include ErbB1, ErbB2, ErbB3 and ErbB4. ErbB4 is a tyrosine kinase receptor that binds neuregulins (NRG) and several other EGF family members. Reverse transcriptase polymerase chain reaction (RT-PCR) analysis identified two isoforms of ErbB4 that differed in their cytoplasmic domain sequences. Specifically, RT-PCR using primers flanking the putative phosphatidyl inositol 3-kinase (PI3-K) binding site of ErbB4 generated two specific bands when human and mouse heart and kidney tissues were analysed. Cloning and sequencing of these RT-PCR products revealed that one of the ErbB4 isoforms (ErbB4 CYT-2) lacked a 16 amino acid sequence including a putative PI3-K binding site, that was present in the other isoform (ErbB4 CYT-1). RT-PCR analysis of mouse tissues suggested that the expression of ErbB4 CYT-1 and ErbB4 CYT-2 was tissue-specific. Heart, breast and abdominal aorta expressed predominantly ErbB4 CYT-1 whereas neural tissues and kidney expressed predominantly ErbB4 CYT-2. To ascertain whether the absence of the putative PI3-K binding site in ErbB4 CYT-2 also resulted in the loss of PI3-K activity, NIH3T3 cell lines overexpressing ErbB4 CYT-1 or ErbB4 CYT-2 were produced. NRG-1 bound to and stimulated equivalent tyrosine phosphorylation of both isoforms. However, unlike ErbB4 CYT-1, the ErbB4 CYT-2 isoform was unable to bind the p85 subunit of PI3-K and to stimulate PI3-K activity in these cells. Furthermore, tyrosine phosphorylation of p85 or association of PI3-K activity with phosphotyrosine was not induced in NRG-1 treated cells expressing ErbB4 CYT-2, indicating that this isoform was incapable of activating PI3-K even indirectly. It was concluded that a novel naturally occurring ErbB4 isoform exists with a deletion of the cytoplasmic domain sequence required for the activation of the PI3-K intracellular signal transduction pathway and that this is the only PI3-K binding site in ErbB4.
Insights
A newly discovered ErbB4 receptor tyrosine kinase isoform, ErbB4 CYT-2, lacks a key binding site for phosphatidyl inositol 3-kinase (PI3-K). This difference prevents ErbB4 CYT-2 from activating the PI3-K signaling pathway, unlike the ErbB4 CYT-1 isoform.
Area of Science:
- Cellular signaling
- Molecular biology
- Biochemistry
Background:
- Receptor tyrosine kinases (RTKs) are crucial regulators of cell behavior.
- The epidermal growth factor (EGF) receptor family includes ErbB1-4.
- ErbB4 binds neuregulins (NRG) and other EGF family members, initiating signal transduction cascades.
Purpose of the Study:
- To identify and characterize novel isoforms of ErbB4.
- To investigate the functional consequences of variations in the ErbB4 cytoplasmic domain.
- To determine if ErbB4 isoforms differ in their ability to activate the phosphatidyl inositol 3-kinase (PI3-K) pathway.
Main Methods:
- Reverse transcriptase polymerase chain reaction (RT-PCR) was used to detect ErbB4 isoforms in human and mouse tissues.
- Cloning and sequencing identified two ErbB4 isoforms: ErbB4 CYT-1 and ErbB4 CYT-2.
- NIH3T3 cell lines overexpressing each isoform were created to study PI3-K binding and activity.
Main Results:
- Two ErbB4 isoforms, ErbB4 CYT-1 and ErbB4 CYT-2, were identified, differing in a 16 amino acid sequence within the cytoplasmic domain.
- ErbB4 CYT-2 lacks a putative PI3-K binding site present in ErbB4 CYT-1.
- Tissue-specific expression patterns were observed for the two isoforms.
- ErbB4 CYT-2 could not bind or activate PI3-K, even indirectly, upon NRG-1 stimulation, while ErbB4 CYT-1 could.
Conclusions:
- A novel, naturally occurring ErbB4 isoform (ErbB4 CYT-2) lacks the cytoplasmic domain sequence essential for PI3-K pathway activation.
- This deletion renders ErbB4 CYT-2 incapable of binding or activating PI3-K, distinguishing its signaling function from ErbB4 CYT-1.
- The findings reveal differential regulation of intracellular signaling by ErbB4 isoforms.